Skip to main content
Top
Published in: Strahlentherapie und Onkologie 9/2017

Open Access 01-09-2017 | Original Article

Single vs. multiple fraction regimens for palliative radiotherapy treatment of multiple myeloma

A prospective randomised study

Authors: Dr. Milda Rudzianskiene, Prof. Arturas Inciura, Dr. Rolandas Gerbutavicius, Dr. Viktoras Rudzianskas, Prof. Andrius Macas, Dr. Renata Simoliuniene, Ruta Dambrauskiene, Greta Emilia Kiavialaitis, Prof. Elona Juozaityte

Published in: Strahlentherapie und Onkologie | Issue 9/2017

Login to get access

Abstract

Purpose

To compare the impact of a single fraction (8 Gy × 1 fraction) and multifraction (3 Gy × 10 fractions) radiotherapy regimens on pain relief, recalcification and the quality of life (QoL) in patients with bone destructions due to multiple myeloma (MM).

Patients and methods

In all, 101 patients were included in a randomised prospective clinical trial: 58 patients were included in the control arm (3 Gy × 10 fractions) and 43 patients into the experimental arm (8 Gy × 1 fraction). The response rate was defined according to the International Consensus on Palliative Radiotherapy criteria. Recalcification was evaluated with radiographs. QoL questionnaires were completed before and 4 weeks after treatment.

Results

Pain relief was obtained in 81/101 patients (80.2%): complete response in 56 (69%) and partial in 25 patients (30.9%). No significant differences were observed in analgesic response between the groups. Significant factors for pain relief were female gender, age under 65, IgG MM type, presence of recalcification at the irradiated site. Recalcification was found in 32/101 patients (33.7%): complete in 17 (53.2%) and partial in 15 (46.2%). No significant differences were observed in recalcification between the groups. Significant factors for recalcification were Karnofsky index ≥ 60%, haemoglobin level ≤ 80 g/dl, MM stage II and analgesic response at the irradiated site. The QoL after radiotherapy was improved in the control group.

Conclusion

The same analgesic and recalcification response was observed using two different radiotherapy regimens. Higher doses should be used to achieve a better QoL.
Literature
2.
go back to reference Raje N, Roodman GD (2011) Advances in the biology and treatment of bone disease in mutiple myeloma. Clin Cancer Res 17:1278–1286CrossRefPubMed Raje N, Roodman GD (2011) Advances in the biology and treatment of bone disease in mutiple myeloma. Clin Cancer Res 17:1278–1286CrossRefPubMed
3.
go back to reference Terpos E, Morgan G, Dimopoulos MA et al (2013) International Myeloma Working Group recommendations for the treatment of multiple myeloma – related bone disease. J Clin Oncol 31:2347–2357CrossRefPubMedPubMedCentral Terpos E, Morgan G, Dimopoulos MA et al (2013) International Myeloma Working Group recommendations for the treatment of multiple myeloma – related bone disease. J Clin Oncol 31:2347–2357CrossRefPubMedPubMedCentral
4.
go back to reference Stolting T, Knauerhase H, Klautke G et al (2008) Total and single doses influence the effectiveness of radiotherapy in palliative treatment of plasmocytoma. Strahlenther Oncol 184:465–472CrossRef Stolting T, Knauerhase H, Klautke G et al (2008) Total and single doses influence the effectiveness of radiotherapy in palliative treatment of plasmocytoma. Strahlenther Oncol 184:465–472CrossRef
5.
go back to reference Adamietz IA, Schober C, Schulte RW et al (1991) Palliative radiotherapy in plasma cell myeloma. Radiother Oncol 20:111–116CrossRefPubMed Adamietz IA, Schober C, Schulte RW et al (1991) Palliative radiotherapy in plasma cell myeloma. Radiother Oncol 20:111–116CrossRefPubMed
6.
go back to reference Balducci M, Chiesa S, Manfrida S et al (2011) Impact of radiotherapy on pain relief and recalcification in plasma cell neoplasms: long-term experience. Strahlenther Onkol 187:114–119CrossRefPubMed Balducci M, Chiesa S, Manfrida S et al (2011) Impact of radiotherapy on pain relief and recalcification in plasma cell neoplasms: long-term experience. Strahlenther Onkol 187:114–119CrossRefPubMed
7.
go back to reference Bosch A, Frias Z (1988) Radiotherapy in the treatment of the multiple myeloma. Int J Radiat Oncol Biol Phys 15:1363–1369CrossRefPubMed Bosch A, Frias Z (1988) Radiotherapy in the treatment of the multiple myeloma. Int J Radiat Oncol Biol Phys 15:1363–1369CrossRefPubMed
8.
go back to reference Yaneva MP, Goranova-Marinova V, Goranov S (2006) Palliative radiotherapy in patients with multiple myeloma. J BUON 11:43–48PubMed Yaneva MP, Goranova-Marinova V, Goranov S (2006) Palliative radiotherapy in patients with multiple myeloma. J BUON 11:43–48PubMed
9.
go back to reference Leigh BR, Kurtts TA, Curtis FM et al (1993) Radiation therapy for the palliation of multiple myeloma. Int J Radiat Oncol Biol Phys 25(25):801–804CrossRefPubMed Leigh BR, Kurtts TA, Curtis FM et al (1993) Radiation therapy for the palliation of multiple myeloma. Int J Radiat Oncol Biol Phys 25(25):801–804CrossRefPubMed
10.
go back to reference Minowa Y, Sasai K, Ishigaki T et al (1996) Palliative radiation therapy for multiple myeloma. Nippon Igaku Hoshasen Gakkai Zasshi 56:1056–1060PubMed Minowa Y, Sasai K, Ishigaki T et al (1996) Palliative radiation therapy for multiple myeloma. Nippon Igaku Hoshasen Gakkai Zasshi 56:1056–1060PubMed
11.
go back to reference Mose S, Pfitzner D, Rahn A et al (2000) Role of radiotherapy in the treatment of multiple myeloma. Strahlenther Oncol 176:506–512CrossRef Mose S, Pfitzner D, Rahn A et al (2000) Role of radiotherapy in the treatment of multiple myeloma. Strahlenther Oncol 176:506–512CrossRef
12.
go back to reference Manfrida S, Chiesa S, Rossi E et al (2010) Impact of radiotherapy on pain relief and recalcification in patients affected by plasma cell neoplasms: a long term experience. J Clin Oncol 28(suppl):e18558CrossRef Manfrida S, Chiesa S, Rossi E et al (2010) Impact of radiotherapy on pain relief and recalcification in patients affected by plasma cell neoplasms: a long term experience. J Clin Oncol 28(suppl):e18558CrossRef
13.
go back to reference Chow E, Harris K, Fan G et al (2007) Palliative radiotherapy trials for bone metastases: a systematic review. J Clin Oncol 25:1423–1436CrossRefPubMed Chow E, Harris K, Fan G et al (2007) Palliative radiotherapy trials for bone metastases: a systematic review. J Clin Oncol 25:1423–1436CrossRefPubMed
14.
go back to reference Foro Arnalot P, Fontanals AV, Galcerán JC et al (2008) Randomized clinical trial with two palliative radiotherapy regimens in painful bone metastases: 30 Gy in 10 fractions compared with 8 Gy in single fraction. Radiother Oncol 89:150–155CrossRefPubMed Foro Arnalot P, Fontanals AV, Galcerán JC et al (2008) Randomized clinical trial with two palliative radiotherapy regimens in painful bone metastases: 30 Gy in 10 fractions compared with 8 Gy in single fraction. Radiother Oncol 89:150–155CrossRefPubMed
15.
go back to reference Sande TA, Ruenes R, Lund JA et al (2009) Long-term follow-up of cancer patients receiving radiotherapy for bone metastases: results from a randomised multicentre trial. Radiother Oncol 91:261–266CrossRefPubMed Sande TA, Ruenes R, Lund JA et al (2009) Long-term follow-up of cancer patients receiving radiotherapy for bone metastases: results from a randomised multicentre trial. Radiother Oncol 91:261–266CrossRefPubMed
16.
go back to reference Bone Pain Trial Working Party. (1999) 8 Gy single fraction radiotherapy for the treatment of metastatic skeletal pain: randomized comparison with a multifraction schedule over 12 months of patient follow-up. Bone Pain Trial Working Party. Radiother Oncol 52:111–121CrossRef Bone Pain Trial Working Party. (1999) 8 Gy single fraction radiotherapy for the treatment of metastatic skeletal pain: randomized comparison with a multifraction schedule over 12 months of patient follow-up. Bone Pain Trial Working Party. Radiother Oncol 52:111–121CrossRef
17.
go back to reference International Myeloma Working Group (2003) Criteria for the classification of monoclonal gammopathies multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol 121:749–757CrossRef International Myeloma Working Group (2003) Criteria for the classification of monoclonal gammopathies multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol 121:749–757CrossRef
18.
go back to reference Jensen MP, Karoly P, Braver S (1986) The measurement of clinical pain intensity: a comparison of six methods. Pain 27:117–126CrossRefPubMed Jensen MP, Karoly P, Braver S (1986) The measurement of clinical pain intensity: a comparison of six methods. Pain 27:117–126CrossRefPubMed
19.
go back to reference Chow E, Doyle M, Li K et al (2006) Mild, moderate or severe pain categorized by patients with cancer with bone metastases. J Pall Med 9:850–854CrossRef Chow E, Doyle M, Li K et al (2006) Mild, moderate or severe pain categorized by patients with cancer with bone metastases. J Pall Med 9:850–854CrossRef
21.
go back to reference Aaronson NK, Ahmedzai S, Bergman B et al (1993) The European Organization for Research and Treatment of Cancer QLQ – C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376CrossRefPubMed Aaronson NK, Ahmedzai S, Bergman B et al (1993) The European Organization for Research and Treatment of Cancer QLQ – C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376CrossRefPubMed
22.
go back to reference Stead ML, Brown JM, Velikova G et al (1999) Development of an EORTC questionnaire module to be used in health-related quality-of-life assessment for patients with multiple myeloma. Br J Haematol 104:605–611CrossRefPubMed Stead ML, Brown JM, Velikova G et al (1999) Development of an EORTC questionnaire module to be used in health-related quality-of-life assessment for patients with multiple myeloma. Br J Haematol 104:605–611CrossRefPubMed
23.
go back to reference Fayers P, Aaronson NK, Bjordal K, Curran D, Bottomley A (2001) EORTC QLQ – C30 scoring manual, 3rd edn. EORTC, Brussels Fayers P, Aaronson NK, Bjordal K, Curran D, Bottomley A (2001) EORTC QLQ – C30 scoring manual, 3rd edn. EORTC, Brussels
24.
go back to reference Chow E, Wu JS, Hoskin P et al (2002) International consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases. Radiother Oncol 64:275–280CrossRefPubMed Chow E, Wu JS, Hoskin P et al (2002) International consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases. Radiother Oncol 64:275–280CrossRefPubMed
25.
go back to reference Harada H, Katagiri H, Kamata M et al (2010) Radiological response and clinical outcome in patients with femoral bone metastases after radiotherapy. J Radiat Res 5:131–136CrossRef Harada H, Katagiri H, Kamata M et al (2010) Radiological response and clinical outcome in patients with femoral bone metastases after radiotherapy. J Radiat Res 5:131–136CrossRef
26.
go back to reference Cox JD, Stetz J, Pajak TF (1995) Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31(5):1341–1346CrossRefPubMed Cox JD, Stetz J, Pajak TF (1995) Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31(5):1341–1346CrossRefPubMed
27.
go back to reference Sze WM, Shelley MD, Held I et al (2003) Palliation of metastatic bone pain: single fraction versus multifraction radiotherapy – a systematic review of randomized trials. Clin Oncol 15:345–352CrossRef Sze WM, Shelley MD, Held I et al (2003) Palliation of metastatic bone pain: single fraction versus multifraction radiotherapy – a systematic review of randomized trials. Clin Oncol 15:345–352CrossRef
28.
go back to reference Wu JS, Wong R, Johnston M et al (2003) Meta-analysis of dose-fractionation radiotherapy trials for the palliation of painful bone metastases. Int J Radiat Oncol Biol Phys 55:594–605CrossRefPubMed Wu JS, Wong R, Johnston M et al (2003) Meta-analysis of dose-fractionation radiotherapy trials for the palliation of painful bone metastases. Int J Radiat Oncol Biol Phys 55:594–605CrossRefPubMed
29.
go back to reference Koswig S, Budach V (1999) Remineralization and pain relief in bone metastases after after different radiotherapy fractions (10 times 3 Gy vs. 1 time 8 Gy). A prospective study. Strahlenther Onkol 175:500–508CrossRefPubMed Koswig S, Budach V (1999) Remineralization and pain relief in bone metastases after after different radiotherapy fractions (10 times 3 Gy vs. 1 time 8 Gy). A prospective study. Strahlenther Onkol 175:500–508CrossRefPubMed
31.
go back to reference Mols F, Oerlemans S, Vos AH et al (2012) Health-related quality of life and disease-specific complaints among multiple myeloma patients up to 10 yr after diagnosis: results from a population-based study using the PROFILES registry. Eur J Haematol 89:311–319CrossRefPubMed Mols F, Oerlemans S, Vos AH et al (2012) Health-related quality of life and disease-specific complaints among multiple myeloma patients up to 10 yr after diagnosis: results from a population-based study using the PROFILES registry. Eur J Haematol 89:311–319CrossRefPubMed
32.
go back to reference Steenland E, Leer JW, van Houwelingen H et al (1999) The effect of a single fraction compared to multiple fractions on painful bone metastases: a global analysis of the Dutch Bone Metastasis Study. Radiother Oncol 52:101–109CrossRefPubMed Steenland E, Leer JW, van Houwelingen H et al (1999) The effect of a single fraction compared to multiple fractions on painful bone metastases: a global analysis of the Dutch Bone Metastasis Study. Radiother Oncol 52:101–109CrossRefPubMed
33.
go back to reference Zeng L, Chow E, Bedard G et al (2012) Quality of life after palliative radiation therapy for patients with painful bone metastases: results of an international study validating the EORTC QLQ – BM22. Int J Radiat Oncol Biol Phys 84:e337–e342CrossRefPubMed Zeng L, Chow E, Bedard G et al (2012) Quality of life after palliative radiation therapy for patients with painful bone metastases: results of an international study validating the EORTC QLQ – BM22. Int J Radiat Oncol Biol Phys 84:e337–e342CrossRefPubMed
34.
go back to reference Caissie A, Zeng L, Nguyen J et al (2012) Assessment of health-related quality of life with the European Organization for Research and Treatment of Cancer QLQ – C15-PAL after palliative radiotherapy of bone metastases. Clin Oncol (R Coll Radiol) 24:125–133CrossRef Caissie A, Zeng L, Nguyen J et al (2012) Assessment of health-related quality of life with the European Organization for Research and Treatment of Cancer QLQ – C15-PAL after palliative radiotherapy of bone metastases. Clin Oncol (R Coll Radiol) 24:125–133CrossRef
35.
go back to reference Valesin Filho ES, de Abreu LC, Lima GH et al (2013) Pain and quality of life in patients undergoing radiotherapy for spinal metastatic disease treatment. Int Arch Med 6:6CrossRefPubMedPubMedCentral Valesin Filho ES, de Abreu LC, Lima GH et al (2013) Pain and quality of life in patients undergoing radiotherapy for spinal metastatic disease treatment. Int Arch Med 6:6CrossRefPubMedPubMedCentral
36.
go back to reference Sauer N, Leising D, Wild B et al (2006) Pain and quality of life following palliative radiotherapy of bone metastases. Strahlenther Onkol 182:550–556CrossRefPubMed Sauer N, Leising D, Wild B et al (2006) Pain and quality of life following palliative radiotherapy of bone metastases. Strahlenther Onkol 182:550–556CrossRefPubMed
37.
go back to reference Lam K, Chow E, Zhang L et al (2013) Determinants of quality of life in advanced cancer patients with bone metastases undergoing palliative radiation treatment. Support Care Cancer 21:3021–3030CrossRefPubMed Lam K, Chow E, Zhang L et al (2013) Determinants of quality of life in advanced cancer patients with bone metastases undergoing palliative radiation treatment. Support Care Cancer 21:3021–3030CrossRefPubMed
38.
go back to reference Caissie A, Culleton S, Nguyen J et al (2012) EORTC QLQ-C15-PAL quality of life scores in patients with advanced cancer referred for palliative radiotherapy. Support Care Cancer 20:841–848CrossRefPubMed Caissie A, Culleton S, Nguyen J et al (2012) EORTC QLQ-C15-PAL quality of life scores in patients with advanced cancer referred for palliative radiotherapy. Support Care Cancer 20:841–848CrossRefPubMed
Metadata
Title
Single vs. multiple fraction regimens for palliative radiotherapy treatment of multiple myeloma
A prospective randomised study
Authors
Dr. Milda Rudzianskiene
Prof. Arturas Inciura
Dr. Rolandas Gerbutavicius
Dr. Viktoras Rudzianskas
Prof. Andrius Macas
Dr. Renata Simoliuniene
Ruta Dambrauskiene
Greta Emilia Kiavialaitis
Prof. Elona Juozaityte
Publication date
01-09-2017
Publisher
Springer Berlin Heidelberg
Published in
Strahlentherapie und Onkologie / Issue 9/2017
Print ISSN: 0179-7158
Electronic ISSN: 1439-099X
DOI
https://doi.org/10.1007/s00066-017-1154-5

Other articles of this Issue 9/2017

Strahlentherapie und Onkologie 9/2017 Go to the issue